Kidney cancer (English Wikipedia)

"Renal Cell Cancer Treatment". National Cancer Institute. 2019. Archived from the original on 10 April 2019. Retrieved 8 June 2019.
"Transitional Cell Cancer (Kidney/Ureter) Treatment". National Cancer Institute. 2019. Archived from the original on 8 June 2019. Retrieved 8 June 2019.
"Wilms Tumor and Other Childhood Kidney Tumors Treatment". National Cancer Institute. 2019. Archived from the original on 10 April 2019. Retrieved 8 June 2019.
"Kidney Cancer". National Cancer Institute. 2019. Archived from the original on 15 August 2020. Retrieved 8 June 2019.
"Renal Cell Cancer Treatment (PDQ®)–Patient Version". National Cancer Institute. 2004-02-20. Archived from the original on 2019-04-10. Retrieved 2019-11-12.
"Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Patient Version". National Cancer Institute. 2004-02-20. Archived from the original on 2019-06-08. Retrieved 2019-11-12.

seer.cancer.gov

"Cancer of the Kidney and Renal Pelvis - Cancer Stat Facts". SEER. Archived from the original on 11 June 2019. Retrieved 30 May 2019.
"Cancer of the Kidney and Renal Pelvis – SEER Stat Fact Sheets". National Cancer Institute, U.S. National Institutes of Health. Archived from the original on 2016-03-29. Retrieved 2013-02-07.
Lynch CF, West MM, Davila JA, Platz CE (2007). "Chapter 24: Cancers of the Kidney and Renal Pelvic". In Ries L, Young JL, Keel GE, Eisner MP, Horner MJ (eds.). SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988–2001, Patient and Tumor Characteristics. Vol. NIH Pub. No. 07-6215. Bethesda, MD: National Cancer Institute. pp. 193–202. Archived from the original on 2013-10-10.

cancer.net

"Kidney Cancer - Risk Factors and Prevention". Cancer.Net. 2012-06-25. Archived from the original on 2019-12-02. Retrieved 2019-12-02.

cancer.org

"Kidney Cancer Stages | Renal Cell Carcinoma Staging". www.cancer.org. Archived from the original on 2019-07-27. Retrieved 2019-11-12.
"Kidney Cancer Stages". cancer.org. Archived from the original on 2019-07-27. Retrieved 2019-11-12. Last Revised: February 1, 2020

old.cancer.org

"Kidney Cancer (Adult) – Renal Cell Carcinoma" (PDF). American Cancer Society. Archived from the original (PDF) on 2017-02-22. Last Revised: May 16, 2016

cancercare.org

media.cancercare.org

Jonasch, Eric, Messner, Carolyn (August 2012). "CancerCare Connect – Treatment Update: Kidney Cancer" (PDF). Cancer Care, Inc. Archived from the original (PDF) on 2011-09-25. Retrieved 2012-08-29.

cancerresearchuk.org

cancerhelp.cancerresearchuk.org

"Risks and causes of kidney cancer". 2017-08-30. Archived from the original on 2011-10-27. Retrieved 2011-11-30.
"Early stage and locally advanced kidney cancer treatment". 2017-08-30. Archived from the original on 2012-10-10. Retrieved 2011-11-30.
"Advanced kidney cancer". 2017-08-30. Archived from the original on 2012-10-10. Retrieved 2011-11-30.
"Biological therapy for kidney cancer". 2017-08-30. Archived from the original on 2011-11-28. Retrieved 2011-11-30.
"Wilms' tumour (kidney cancer in children)". 2017-08-30. Archived from the original on 2012-04-06.

cancerresearchuk.org

"Kidney cancer statistics". Cancer Research UK. Archived from the original on 17 October 2014. Retrieved 27 October 2014.

cdc.gov

"Kidney Cancer | CDC". www.cdc.gov. 2019-07-09. Archived from the original on 2019-11-12. Retrieved 2019-11-12.

doi.org

Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, Wang N (2018). "Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries". The Lancet Global Health. 6 (5): e555 – e567. doi:10.1016/S2214-109X(18)30127-X. hdl:10072/386179. PMID 29653628.
Scelo G, Larose TL (2018-12-20). "Epidemiology and Risk Factors for Kidney Cancer". Journal of Clinical Oncology. 36 (36): 3574–3581. doi:10.1200/JCO.2018.79.1905. ISSN 0732-183X. PMC 6299342. PMID 30372394.
Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, Rawla P, Barsouk A (June 2020). "Epidemiology of Renal Cell Carcinoma". World Journal of Oncology. 11 (3): 79–87. doi:10.14740/wjon1279. ISSN 1920-4531. PMC 7239575. PMID 32494314.
Pascual D, Borque A (2008-11-04). "Epidemiology of Kidney Cancer". Advances in Urology. 2008: e782381. doi:10.1155/2008/782381. ISSN 1687-6369. PMC 2581742. PMID 19009036.
Hidayat K, Du X, Zou SY, Shi BM (July 2017). "Blood pressure and kidney cancer risk: meta-analysis of prospective studies". Journal of Hypertension. 35 (7): 1333–1344. doi:10.1097/HJH.0000000000001286. PMID 28157813. S2CID 3454741.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T (2019-05-01). "European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update". European Urology. 75 (5): 799–810. doi:10.1016/j.eururo.2019.02.011. ISSN 0302-2838.
Tahbaz R, Schmid M, Merseburger AS (2018). "Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition". Current Opinion in Urology. 28 (1): 62–79. doi:10.1097/MOU.0000000000000454. ISSN 1473-6586. PMID 29059103. S2CID 25998957.
Cheungpasitporn W, Thongprayoon C, O'Corragain OA, Edmonds PJ, Ungprasert P, Kittanamongkolchai W, Erickson SB (9 September 2014). "The Risk of Kidney Cancer in Patients with Kidney Stones: A Systematic Review and Meta-analysis". QJM. 108 (3): 205–12. doi:10.1093/qjmed/hcu195. PMID 25208892.
Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P (2005-03-10). "Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies". International Journal of Cancer. 114 (1): 101–108. doi:10.1002/ijc.20618. ISSN 0020-7136. PMID 15523697. S2CID 10136386.
Sánchez-Martín FM, Millán-Rodríguez F, Urdaneta-Pignalosa G, Rubio-Briones J, Villavicencio-Mavrich H (2008). "Small Renal Masses: Incidental Diagnosis, Clinical Symptoms, and Prognostic Factors". Advances in Urology. 2008: 310694. doi:10.1155/2008/310694. ISSN 1687-6369. PMC 2629071. PMID 19165347.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Toni Choueiri, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Silverman SG, Israel GM, Herts BR, Richie JP (October 2008). "Management of the incidental renal mass". Radiology. 249 (1): 16–31. doi:10.1148/radiol.2491070783. ISSN 1527-1315. PMID 18796665. S2CID 23327389.
Israel GM, Bosniak MA (2005). "How I Do It: Evaluating Renal Masses". Radiology. 236 (2): 441–450. doi:10.1148/radiol.2362040218. ISSN 0033-8419. PMID 16040900. S2CID 1916092.
Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, Remer EM, Shinagare AB, Curci NE, Raman SS, Wells SA (2019-06-18). "Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment". Radiology. 292 (2): 475–488. doi:10.1148/radiol.2019182646. ISSN 0033-8419. PMC 6677285. PMID 31210616.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Kuroda N, Katto K, Tamura M, Shiotsu T, Hes O, Michal M, Nagashima Y, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Lee GH (January 2008). "Carcinoid tumor of the renal pelvis: consideration on the histogenesis". Pathol. Int. 58 (1): 51–4. doi:10.1111/j.1440-1827.2007.02188.x. PMID 18067641. S2CID 27645211.
Chiu KC, Lin MC, Liang YC, Chen CY (2008). "Renal carcinosarcoma: case report and review of literature". Renal Failure. 30 (10): 1034–9. doi:10.1080/08860220802403192. PMID 19016157.
Picozzi S, Casellato S, Bozzini G, Ratti D, Macchi A, Rubino B, Pace G, Carmignani L (November 2013). "Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients". Urologic Oncology. 31 (8): 1584–1590. doi:10.1016/j.urolonc.2012.03.009. ISSN 1873-2496. PMID 22520573.
Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z (May 2006). "2004 WHO classification of the renal tumors of the adults". European Urology. 49 (5): 798–805. doi:10.1016/j.eururo.2005.11.035. ISSN 0302-2838. PMID 16442207.
Thyavihally YB, Tongaonkar HB, Desai SB (September 2005). "Benign mixed epithelial stromal tumor of the renal pelvis with exophytic growth: case report". Int Semin Surg Oncol. 2: 18. doi:10.1186/1477-7800-2-18. PMC 1215508. PMID 16150156.
Mantilla JG, Antic T, Tretiakova M (2017). "GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics". Hum Pathol. 66: 152–158. doi:10.1016/j.humpath.2017.06.016. PMID 28705707. Archived from the original on 2024-07-07. Retrieved 2023-08-28.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME (May 2016). "Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature". The Journal of Urology. 195 (5): 1340–1347. doi:10.1016/j.juro.2015.11.029. ISSN 1527-3792. PMC 5609078. PMID 26901507.
Swami U, Nussenzveig RH, Haaland B, Agarwal N (2019). "Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement". Annals of Translational Medicine. 7 (S1): S18. doi:10.21037/atm.2019.01.50. ISSN 2305-5839. PMC 6462602. PMID 31032299.
Choueiri TK, et al. (2021-08-19). "Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma". New England Journal of Medicine. 385 (8): 683–694. doi:10.1056/nejmoa2106391. PMID 34407342. S2CID 237215136.
Syn NL, Teng MW, Mok TS, Soo RA (2017). "De-novo and acquired resistance to immune checkpoint targeting". The Lancet Oncology. 18 (12): e731 – e741. doi:10.1016/s1470-2045(17)30607-1. PMID 29208439.
Philips GK, Atkins MB (2014). "New agents and new targets for renal cell carcinoma". American Society of Clinical Oncology Educational Book / ASCO. American Society of Clinical Oncology. Meeting. 34 (34): e222-7. doi:10.14694/EdBook_AM.2014.34.e222. PMID 24857106.
Klaassen Z, Sayyid RK, Wallis CJ (2019). "Lessons Learned from the Global Epidemiology of Kidney Cancer: A Refresher in Epidemiology 101". European Urology. 75 (1): 85–87. doi:10.1016/j.eururo.2018.09.035. PMID 30274700. S2CID 52900491. Archived from the original on 2022-06-15. Retrieved 2021-12-01.
Ferlay J, et al. (2007). "Estimates of the cancer incidence and mortality in Europe in 2006". Annals of Oncology. 18 (3): 581–92. doi:10.1093/annonc/mdl498. PMID 17287242.

elsevier.com

linkinghub.elsevier.com

Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T (2019-05-01). "European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update". European Urology. 75 (5): 799–810. doi:10.1016/j.eururo.2019.02.011. ISSN 0302-2838.
Klaassen Z, Sayyid RK, Wallis CJ (2019). "Lessons Learned from the Global Epidemiology of Kidney Cancer: A Refresher in Epidemiology 101". European Urology. 75 (1): 85–87. doi:10.1016/j.eururo.2018.09.035. PMID 30274700. S2CID 52900491. Archived from the original on 2022-06-15. Retrieved 2021-12-01.

encr.eu

"European Network of Cancer Registeries" (PDF). Archived (PDF) from the original on 2020-12-29. Retrieved 2019-12-02.

fda.gov

accessdata.fda.gov

"Drugs@FDA: FDA Approved Drug Products". Archived from the original on 2021-08-29. Retrieved 2016-04-25.
"CABOMETYX™ (cabozantinib)" (PDF). fda.gov. Archived (PDF) from the original on 30 January 2022. Retrieved 6 July 2024.
"LENVIMA™" (PDF). fda.gov. Archived (PDF) from the original on 24 June 2024. Retrieved 6 July 2024.

fda.gov

"FDA approves Opdivo to treat advanced form of kidney cancer". Food and Drug Administration. Archived from the original on 2018-01-25. Retrieved 2019-12-16.

handle.net

hdl.handle.net

Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, Wang N (2018). "Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries". The Lancet Global Health. 6 (5): e555 – e567. doi:10.1016/S2214-109X(18)30127-X. hdl:10072/386179. PMID 29653628.

hemonc.org

"Renal cell carcinoma | HemOnc.org - A Hematology Oncology Wiki". hemonc.org. Archived from the original on 2016-08-28. Retrieved 2012-05-08.

iarc.fr

gco.iarc.fr

"Cancer today". IARC. Archived from the original on 27 May 2019. Retrieved 30 May 2019.

jnccn.org

Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Toni Choueiri, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.

lexico.com

"Cancer | Definition of Cancer by Lexico". Lexico Dictionaries | English. Archived from the original on November 12, 2019. Retrieved 2019-11-12.

nccn.org

"National Comprehensive Cancer Network" (PDF). Archived (PDF) from the original on 2009-03-06. Retrieved 2012-05-08.

nih.gov

pubmed.ncbi.nlm.nih.gov

Mulders PF, Brouwers AH, Hulsbergen-van der Kaa CA, van Lin EN, Osanto S, de Mulder PH (February 2008). "[Guideline 'Renal cell carcinoma']". Ned Tijdschr Geneeskd (in Dutch). 152 (7): 376–80. PMID 18380384.
Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, Wang N (2018). "Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries". The Lancet Global Health. 6 (5): e555 – e567. doi:10.1016/S2214-109X(18)30127-X. hdl:10072/386179. PMID 29653628.
Scelo G, Larose TL (2018-12-20). "Epidemiology and Risk Factors for Kidney Cancer". Journal of Clinical Oncology. 36 (36): 3574–3581. doi:10.1200/JCO.2018.79.1905. ISSN 0732-183X. PMC 6299342. PMID 30372394.
Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, Rawla P, Barsouk A (June 2020). "Epidemiology of Renal Cell Carcinoma". World Journal of Oncology. 11 (3): 79–87. doi:10.14740/wjon1279. ISSN 1920-4531. PMC 7239575. PMID 32494314.
Pascual D, Borque A (2008-11-04). "Epidemiology of Kidney Cancer". Advances in Urology. 2008: e782381. doi:10.1155/2008/782381. ISSN 1687-6369. PMC 2581742. PMID 19009036.
Hidayat K, Du X, Zou SY, Shi BM (July 2017). "Blood pressure and kidney cancer risk: meta-analysis of prospective studies". Journal of Hypertension. 35 (7): 1333–1344. doi:10.1097/HJH.0000000000001286. PMID 28157813. S2CID 3454741.
Palapattu GS, Kristo B, Rajfer J (2002). "Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma". Reviews in Urology. 4 (4): 163–170. ISSN 1523-6161. PMC 1475999. PMID 16985675.
Tahbaz R, Schmid M, Merseburger AS (2018). "Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition". Current Opinion in Urology. 28 (1): 62–79. doi:10.1097/MOU.0000000000000454. ISSN 1473-6586. PMID 29059103. S2CID 25998957.
Cheungpasitporn W, Thongprayoon C, O'Corragain OA, Edmonds PJ, Ungprasert P, Kittanamongkolchai W, Erickson SB (9 September 2014). "The Risk of Kidney Cancer in Patients with Kidney Stones: A Systematic Review and Meta-analysis". QJM. 108 (3): 205–12. doi:10.1093/qjmed/hcu195. PMID 25208892.
Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P (2005-03-10). "Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies". International Journal of Cancer. 114 (1): 101–108. doi:10.1002/ijc.20618. ISSN 0020-7136. PMID 15523697. S2CID 10136386.
Sánchez-Martín FM, Millán-Rodríguez F, Urdaneta-Pignalosa G, Rubio-Briones J, Villavicencio-Mavrich H (2008). "Small Renal Masses: Incidental Diagnosis, Clinical Symptoms, and Prognostic Factors". Advances in Urology. 2008: 310694. doi:10.1155/2008/310694. ISSN 1687-6369. PMC 2629071. PMID 19165347.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Toni Choueiri, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Silverman SG, Israel GM, Herts BR, Richie JP (October 2008). "Management of the incidental renal mass". Radiology. 249 (1): 16–31. doi:10.1148/radiol.2491070783. ISSN 1527-1315. PMID 18796665. S2CID 23327389.
Israel GM, Bosniak MA (2005). "How I Do It: Evaluating Renal Masses". Radiology. 236 (2): 441–450. doi:10.1148/radiol.2362040218. ISSN 0033-8419. PMID 16040900. S2CID 1916092.
Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, Remer EM, Shinagare AB, Curci NE, Raman SS, Wells SA (2019-06-18). "Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment". Radiology. 292 (2): 475–488. doi:10.1148/radiol.2019182646. ISSN 0033-8419. PMC 6677285. PMID 31210616.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Subramaniam RM, Wilson RF, Turban S, Suarez-Cuervo C, Zhang A, Sherrod C, Aboagye J, Eng J, Choi MJ (2016). Contrast-Induced Nephropathy: Comparative Effectiveness of Preventive Measures. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). PMID 26866209. Archived from the original on 2021-08-28. Retrieved 2019-10-29.
Kuroda N, Katto K, Tamura M, Shiotsu T, Hes O, Michal M, Nagashima Y, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Lee GH (January 2008). "Carcinoid tumor of the renal pelvis: consideration on the histogenesis". Pathol. Int. 58 (1): 51–4. doi:10.1111/j.1440-1827.2007.02188.x. PMID 18067641. S2CID 27645211.
Chiu KC, Lin MC, Liang YC, Chen CY (2008). "Renal carcinosarcoma: case report and review of literature". Renal Failure. 30 (10): 1034–9. doi:10.1080/08860220802403192. PMID 19016157.
Picozzi S, Casellato S, Bozzini G, Ratti D, Macchi A, Rubino B, Pace G, Carmignani L (November 2013). "Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients". Urologic Oncology. 31 (8): 1584–1590. doi:10.1016/j.urolonc.2012.03.009. ISSN 1873-2496. PMID 22520573.
Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z (May 2006). "2004 WHO classification of the renal tumors of the adults". European Urology. 49 (5): 798–805. doi:10.1016/j.eururo.2005.11.035. ISSN 0302-2838. PMID 16442207.
Thyavihally YB, Tongaonkar HB, Desai SB (September 2005). "Benign mixed epithelial stromal tumor of the renal pelvis with exophytic growth: case report". Int Semin Surg Oncol. 2: 18. doi:10.1186/1477-7800-2-18. PMC 1215508. PMID 16150156.
Mantilla JG, Antic T, Tretiakova M (2017). "GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics". Hum Pathol. 66: 152–158. doi:10.1016/j.humpath.2017.06.016. PMID 28705707. Archived from the original on 2024-07-07. Retrieved 2023-08-28.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME (May 2016). "Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature". The Journal of Urology. 195 (5): 1340–1347. doi:10.1016/j.juro.2015.11.029. ISSN 1527-3792. PMC 5609078. PMID 26901507.
Swami U, Nussenzveig RH, Haaland B, Agarwal N (2019). "Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement". Annals of Translational Medicine. 7 (S1): S18. doi:10.21037/atm.2019.01.50. ISSN 2305-5839. PMC 6462602. PMID 31032299.
Choueiri TK, et al. (2021-08-19). "Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma". New England Journal of Medicine. 385 (8): 683–694. doi:10.1056/nejmoa2106391. PMID 34407342. S2CID 237215136.
Syn NL, Teng MW, Mok TS, Soo RA (2017). "De-novo and acquired resistance to immune checkpoint targeting". The Lancet Oncology. 18 (12): e731 – e741. doi:10.1016/s1470-2045(17)30607-1. PMID 29208439.
Philips GK, Atkins MB (2014). "New agents and new targets for renal cell carcinoma". American Society of Clinical Oncology Educational Book / ASCO. American Society of Clinical Oncology. Meeting. 34 (34): e222-7. doi:10.14694/EdBook_AM.2014.34.e222. PMID 24857106.
Klaassen Z, Sayyid RK, Wallis CJ (2019). "Lessons Learned from the Global Epidemiology of Kidney Cancer: A Refresher in Epidemiology 101". European Urology. 75 (1): 85–87. doi:10.1016/j.eururo.2018.09.035. PMID 30274700. S2CID 52900491. Archived from the original on 2022-06-15. Retrieved 2021-12-01.
Ferlay J, et al. (2007). "Estimates of the cancer incidence and mortality in Europe in 2006". Annals of Oncology. 18 (3): 581–92. doi:10.1093/annonc/mdl498. PMID 17287242.

ncbi.nlm.nih.gov

Scelo G, Larose TL (2018-12-20). "Epidemiology and Risk Factors for Kidney Cancer". Journal of Clinical Oncology. 36 (36): 3574–3581. doi:10.1200/JCO.2018.79.1905. ISSN 0732-183X. PMC 6299342. PMID 30372394.
Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, Rawla P, Barsouk A (June 2020). "Epidemiology of Renal Cell Carcinoma". World Journal of Oncology. 11 (3): 79–87. doi:10.14740/wjon1279. ISSN 1920-4531. PMC 7239575. PMID 32494314.
Pascual D, Borque A (2008-11-04). "Epidemiology of Kidney Cancer". Advances in Urology. 2008: e782381. doi:10.1155/2008/782381. ISSN 1687-6369. PMC 2581742. PMID 19009036.
Palapattu GS, Kristo B, Rajfer J (2002). "Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma". Reviews in Urology. 4 (4): 163–170. ISSN 1523-6161. PMC 1475999. PMID 16985675.
Sánchez-Martín FM, Millán-Rodríguez F, Urdaneta-Pignalosa G, Rubio-Briones J, Villavicencio-Mavrich H (2008). "Small Renal Masses: Incidental Diagnosis, Clinical Symptoms, and Prognostic Factors". Advances in Urology. 2008: 310694. doi:10.1155/2008/310694. ISSN 1687-6369. PMC 2629071. PMID 19165347.
Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, Remer EM, Shinagare AB, Curci NE, Raman SS, Wells SA (2019-06-18). "Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment". Radiology. 292 (2): 475–488. doi:10.1148/radiol.2019182646. ISSN 0033-8419. PMC 6677285. PMID 31210616.
Subramaniam RM, Wilson RF, Turban S, Suarez-Cuervo C, Zhang A, Sherrod C, Aboagye J, Eng J, Choi MJ (2016). Contrast-Induced Nephropathy: Comparative Effectiveness of Preventive Measures. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). PMID 26866209. Archived from the original on 2021-08-28. Retrieved 2019-10-29.
Thyavihally YB, Tongaonkar HB, Desai SB (September 2005). "Benign mixed epithelial stromal tumor of the renal pelvis with exophytic growth: case report". Int Semin Surg Oncol. 2: 18. doi:10.1186/1477-7800-2-18. PMC 1215508. PMID 16150156.
Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME (May 2016). "Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature". The Journal of Urology. 195 (5): 1340–1347. doi:10.1016/j.juro.2015.11.029. ISSN 1527-3792. PMC 5609078. PMID 26901507.
Swami U, Nussenzveig RH, Haaland B, Agarwal N (2019). "Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement". Annals of Translational Medicine. 7 (S1): S18. doi:10.21037/atm.2019.01.50. ISSN 2305-5839. PMC 6462602. PMID 31032299.

pathologyoutlines.com

Behtash G. Nezami, M.D., Gregory MacLennan, M.D. "Kidney tumor - Adult renal cell carcinoma - common - Clear cell". Pathology Outlines. Archived from the original on 2021-10-18. Retrieved 2021-10-18.{{cite web}}: CS1 maint: multiple names: authors list (link) Topic Completed: 20 April 2021. Minor changes: 20 April 2021

semanticscholar.org

api.semanticscholar.org

Hidayat K, Du X, Zou SY, Shi BM (July 2017). "Blood pressure and kidney cancer risk: meta-analysis of prospective studies". Journal of Hypertension. 35 (7): 1333–1344. doi:10.1097/HJH.0000000000001286. PMID 28157813. S2CID 3454741.
Tahbaz R, Schmid M, Merseburger AS (2018). "Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition". Current Opinion in Urology. 28 (1): 62–79. doi:10.1097/MOU.0000000000000454. ISSN 1473-6586. PMID 29059103. S2CID 25998957.
Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P (2005-03-10). "Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies". International Journal of Cancer. 114 (1): 101–108. doi:10.1002/ijc.20618. ISSN 0020-7136. PMID 15523697. S2CID 10136386.
Silverman SG, Israel GM, Herts BR, Richie JP (October 2008). "Management of the incidental renal mass". Radiology. 249 (1): 16–31. doi:10.1148/radiol.2491070783. ISSN 1527-1315. PMID 18796665. S2CID 23327389.
Israel GM, Bosniak MA (2005). "How I Do It: Evaluating Renal Masses". Radiology. 236 (2): 441–450. doi:10.1148/radiol.2362040218. ISSN 0033-8419. PMID 16040900. S2CID 1916092.
Kuroda N, Katto K, Tamura M, Shiotsu T, Hes O, Michal M, Nagashima Y, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Lee GH (January 2008). "Carcinoid tumor of the renal pelvis: consideration on the histogenesis". Pathol. Int. 58 (1): 51–4. doi:10.1111/j.1440-1827.2007.02188.x. PMID 18067641. S2CID 27645211.
Choueiri TK, et al. (2021-08-19). "Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma". New England Journal of Medicine. 385 (8): 683–694. doi:10.1056/nejmoa2106391. PMID 34407342. S2CID 237215136.
Klaassen Z, Sayyid RK, Wallis CJ (2019). "Lessons Learned from the Global Epidemiology of Kidney Cancer: A Refresher in Epidemiology 101". European Urology. 75 (1): 85–87. doi:10.1016/j.eururo.2018.09.035. PMID 30274700. S2CID 52900491. Archived from the original on 2022-06-15. Retrieved 2021-12-01.

uroweb.org

Professionals SO. "EAU Guidelines: Renal Cell Carcinoma". Uroweb. Archived from the original on 2019-08-13. Retrieved 2019-12-03.

web.archive.org

"Renal Cell Cancer Treatment". National Cancer Institute. 2019. Archived from the original on 10 April 2019. Retrieved 8 June 2019.
"Transitional Cell Cancer (Kidney/Ureter) Treatment". National Cancer Institute. 2019. Archived from the original on 8 June 2019. Retrieved 8 June 2019.
"Wilms Tumor and Other Childhood Kidney Tumors Treatment". National Cancer Institute. 2019. Archived from the original on 10 April 2019. Retrieved 8 June 2019.
"Cancer of the Kidney and Renal Pelvis - Cancer Stat Facts". SEER. Archived from the original on 11 June 2019. Retrieved 30 May 2019.
"Cancer today". IARC. Archived from the original on 27 May 2019. Retrieved 30 May 2019.
"Kidney Cancer". National Cancer Institute. 2019. Archived from the original on 15 August 2020. Retrieved 8 June 2019.
"Survival statistics for kidney cancer - Canadian Cancer Society". www.cancer.ca. Archived from the original on 2019-06-17. Retrieved 2019-12-02.
"European Network of Cancer Registeries" (PDF). Archived (PDF) from the original on 2020-12-29. Retrieved 2019-12-02.
Professionals SO. "EAU Guidelines: Renal Cell Carcinoma". Uroweb. Archived from the original on 2019-08-13. Retrieved 2019-12-03.
"Kidney Cancer - Risk Factors and Prevention". Cancer.Net. 2012-06-25. Archived from the original on 2019-12-02. Retrieved 2019-12-02.
"Risks and causes of kidney cancer". 2017-08-30. Archived from the original on 2011-10-27. Retrieved 2011-11-30.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Toni Choueiri, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
"Cancer | Definition of Cancer by Lexico". Lexico Dictionaries | English. Archived from the original on November 12, 2019. Retrieved 2019-11-12.
"Renal Cancer: Renal Mass & Localized Renal Cancer Guideline - American Urological Association". www.auanet.org. Archived from the original on 2020-02-15. Retrieved 2019-10-29.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Subramaniam RM, Wilson RF, Turban S, Suarez-Cuervo C, Zhang A, Sherrod C, Aboagye J, Eng J, Choi MJ (2016). Contrast-Induced Nephropathy: Comparative Effectiveness of Preventive Measures. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). PMID 26866209. Archived from the original on 2021-08-28. Retrieved 2019-10-29.
"Kidney Cancer | CDC". www.cdc.gov. 2019-07-09. Archived from the original on 2019-11-12. Retrieved 2019-11-12.
"Renal Cell Cancer Treatment (PDQ®)–Patient Version". National Cancer Institute. 2004-02-20. Archived from the original on 2019-04-10. Retrieved 2019-11-12.
"Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Patient Version". National Cancer Institute. 2004-02-20. Archived from the original on 2019-06-08. Retrieved 2019-11-12.
Mantilla JG, Antic T, Tretiakova M (2017). "GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics". Hum Pathol. 66: 152–158. doi:10.1016/j.humpath.2017.06.016. PMID 28705707. Archived from the original on 2024-07-07. Retrieved 2023-08-28.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Behtash G. Nezami, M.D., Gregory MacLennan, M.D. "Kidney tumor - Adult renal cell carcinoma - common - Clear cell". Pathology Outlines. Archived from the original on 2021-10-18. Retrieved 2021-10-18.{{cite web}}: CS1 maint: multiple names: authors list (link) Topic Completed: 20 April 2021. Minor changes: 20 April 2021
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
"Kidney Cancer Stages | Renal Cell Carcinoma Staging". www.cancer.org. Archived from the original on 2019-07-27. Retrieved 2019-11-12.
"Kidney Cancer Stages". cancer.org. Archived from the original on 2019-07-27. Retrieved 2019-11-12. Last Revised: February 1, 2020
"Kidney Cancer (Adult) – Renal Cell Carcinoma" (PDF). American Cancer Society. Archived from the original (PDF) on 2017-02-22. Last Revised: May 16, 2016
"Early stage and locally advanced kidney cancer treatment". 2017-08-30. Archived from the original on 2012-10-10. Retrieved 2011-11-30.
"Advanced kidney cancer". 2017-08-30. Archived from the original on 2012-10-10. Retrieved 2011-11-30.
"Renal cell carcinoma | HemOnc.org - A Hematology Oncology Wiki". hemonc.org. Archived from the original on 2016-08-28. Retrieved 2012-05-08.
"National Comprehensive Cancer Network" (PDF). Archived (PDF) from the original on 2009-03-06. Retrieved 2012-05-08.
"Biological therapy for kidney cancer". 2017-08-30. Archived from the original on 2011-11-28. Retrieved 2011-11-30.
Jonasch, Eric, Messner, Carolyn (August 2012). "CancerCare Connect – Treatment Update: Kidney Cancer" (PDF). Cancer Care, Inc. Archived from the original (PDF) on 2011-09-25. Retrieved 2012-08-29.
"FDA approves Opdivo to treat advanced form of kidney cancer". Food and Drug Administration. Archived from the original on 2018-01-25. Retrieved 2019-12-16.
"Drugs@FDA: FDA Approved Drug Products". Archived from the original on 2021-08-29. Retrieved 2016-04-25.
"CABOMETYX™ (cabozantinib)" (PDF). fda.gov. Archived (PDF) from the original on 30 January 2022. Retrieved 6 July 2024.
"LENVIMA™" (PDF). fda.gov. Archived (PDF) from the original on 24 June 2024. Retrieved 6 July 2024.
"Wilms' tumour (kidney cancer in children)". 2017-08-30. Archived from the original on 2012-04-06.
Klaassen Z, Sayyid RK, Wallis CJ (2019). "Lessons Learned from the Global Epidemiology of Kidney Cancer: A Refresher in Epidemiology 101". European Urology. 75 (1): 85–87. doi:10.1016/j.eururo.2018.09.035. PMID 30274700. S2CID 52900491. Archived from the original on 2022-06-15. Retrieved 2021-12-01.
"Cancer of the Kidney and Renal Pelvis – SEER Stat Fact Sheets". National Cancer Institute, U.S. National Institutes of Health. Archived from the original on 2016-03-29. Retrieved 2013-02-07.
Lynch CF, West MM, Davila JA, Platz CE (2007). "Chapter 24: Cancers of the Kidney and Renal Pelvic". In Ries L, Young JL, Keel GE, Eisner MP, Horner MJ (eds.). SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988–2001, Patient and Tumor Characteristics. Vol. NIH Pub. No. 07-6215. Bethesda, MD: National Cancer Institute. pp. 193–202. Archived from the original on 2013-10-10.
"Kidney cancer statistics". Cancer Research UK. Archived from the original on 17 October 2014. Retrieved 27 October 2014.

worldcat.org

search.worldcat.org

Scelo G, Larose TL (2018-12-20). "Epidemiology and Risk Factors for Kidney Cancer". Journal of Clinical Oncology. 36 (36): 3574–3581. doi:10.1200/JCO.2018.79.1905. ISSN 0732-183X. PMC 6299342. PMID 30372394.
Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, Rawla P, Barsouk A (June 2020). "Epidemiology of Renal Cell Carcinoma". World Journal of Oncology. 11 (3): 79–87. doi:10.14740/wjon1279. ISSN 1920-4531. PMC 7239575. PMID 32494314.
Pascual D, Borque A (2008-11-04). "Epidemiology of Kidney Cancer". Advances in Urology. 2008: e782381. doi:10.1155/2008/782381. ISSN 1687-6369. PMC 2581742. PMID 19009036.
Palapattu GS, Kristo B, Rajfer J (2002). "Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma". Reviews in Urology. 4 (4): 163–170. ISSN 1523-6161. PMC 1475999. PMID 16985675.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T (2019-05-01). "European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update". European Urology. 75 (5): 799–810. doi:10.1016/j.eururo.2019.02.011. ISSN 0302-2838.
Tahbaz R, Schmid M, Merseburger AS (2018). "Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition". Current Opinion in Urology. 28 (1): 62–79. doi:10.1097/MOU.0000000000000454. ISSN 1473-6586. PMID 29059103. S2CID 25998957.
Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P (2005-03-10). "Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies". International Journal of Cancer. 114 (1): 101–108. doi:10.1002/ijc.20618. ISSN 0020-7136. PMID 15523697. S2CID 10136386.
Sánchez-Martín FM, Millán-Rodríguez F, Urdaneta-Pignalosa G, Rubio-Briones J, Villavicencio-Mavrich H (2008). "Small Renal Masses: Incidental Diagnosis, Clinical Symptoms, and Prognostic Factors". Advances in Urology. 2008: 310694. doi:10.1155/2008/310694. ISSN 1687-6369. PMC 2629071. PMID 19165347.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Toni Choueiri, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Silverman SG, Israel GM, Herts BR, Richie JP (October 2008). "Management of the incidental renal mass". Radiology. 249 (1): 16–31. doi:10.1148/radiol.2491070783. ISSN 1527-1315. PMID 18796665. S2CID 23327389.
Israel GM, Bosniak MA (2005). "How I Do It: Evaluating Renal Masses". Radiology. 236 (2): 441–450. doi:10.1148/radiol.2362040218. ISSN 0033-8419. PMID 16040900. S2CID 1916092.
Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, Remer EM, Shinagare AB, Curci NE, Raman SS, Wells SA (2019-06-18). "Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment". Radiology. 292 (2): 475–488. doi:10.1148/radiol.2019182646. ISSN 0033-8419. PMC 6677285. PMID 31210616.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Picozzi S, Casellato S, Bozzini G, Ratti D, Macchi A, Rubino B, Pace G, Carmignani L (November 2013). "Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients". Urologic Oncology. 31 (8): 1584–1590. doi:10.1016/j.urolonc.2012.03.009. ISSN 1873-2496. PMID 22520573.
Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z (May 2006). "2004 WHO classification of the renal tumors of the adults". European Urology. 49 (5): 798–805. doi:10.1016/j.eururo.2005.11.035. ISSN 0302-2838. PMID 16442207.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH (2017-06-01). "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology". Journal of the National Comprehensive Cancer Network. 15 (6): 804–834. doi:10.6004/jnccn.2017.0100. ISSN 1540-1405. PMID 28596261. Archived from the original on 2019-10-29. Retrieved 2019-10-29.
Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME (May 2016). "Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature". The Journal of Urology. 195 (5): 1340–1347. doi:10.1016/j.juro.2015.11.029. ISSN 1527-3792. PMC 5609078. PMID 26901507.
AJCC cancer staging manual. Edge, Stephen B., American Joint Committee on Cancer. (7th ed.). New York: Springer. 2010. ISBN 9780387884400. OCLC 316431417.{{cite book}}: CS1 maint: others (link)
Swami U, Nussenzveig RH, Haaland B, Agarwal N (2019). "Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement". Annals of Translational Medicine. 7 (S1): S18. doi:10.21037/atm.2019.01.50. ISSN 2305-5839. PMC 6462602. PMID 31032299.